Targeted tumor necrosis factor receptor I preligand assembly domain improves skin lesions in MRL/lpr mice

Guo-Min Deng1, Lena Liu, George C Tsokos

  • 1Division of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, CLS 937, Boston, MA 02115, USA. gdeng@bidmc.harvard.edu

Abstract

Related Concept Videos